Movicol Liquide Goût Orange (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Movicol Liquide Goût Orange, an osmotic laxative, is indicated for conditions affecting bowel transit.

• Constipation: softens stool consistency and increases intestinal water content, thereby facilitating easier and more frequent bowel movements in patients with functional or chronic constipation.
• Faecal impaction: promotes osmotic retention of water in the lumen, helping to soften and dislodge hardened stool masses for safe evacuation.
• Bowel preparation for diagnostic procedures: effectively clears the colon by increasing stool water content, providing a clear intestinal field for colonoscopy, sigmoidoscopy, or radiologic imaging.

• Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that is poorly absorbed from the gastrointestinal tract. It exerts an osmotic effect by retaining water within the intestinal lumen, increasing stool volume and softness. The accompanying electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride) maintain electrolyte balance while enhancing water retention, thereby promoting accelerated colonic transit and facilitating bowel evacuation. This mechanism helps normalize bowel function in patients with reduced motility.

Movicol Liquide Goût Orange may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal bloating: feeling of fullness in the abdomen, generally temporary.
• Nausea: mild to moderate queasiness that may typically appear after dosing.
• Diarrhoea: loose, watery stools occurring more often than usual, usually mild.
• Flatulence: increased intestinal gas causing frequent wind and mild discomfort, often noticeable.
• Cramping: intermittent abdominal muscle pain accompanying bowel activity, usually brief.

Serious or Rare Side Effects

• Severe dehydration: marked fluid loss that can cause dizziness and may need medical care, potentially serious.
• Electrolyte imbalance: abnormal sodium, potassium or chloride levels affecting heart or muscle function, clinically relevant.
• Allergic reaction: rash, itching, facial swelling or breathing difficulty indicating hypersensitivity, may be severe.
• Persistent abdominal pain: ongoing severe pain not relieved by usual measures, requiring persistent evaluation.

When using Movicol Liquide Goût Orange, certain precautions should be observed to ensure safe and effective therapy.

• Assess renal function: evaluate kidney status before initiating therapy, especially in patients with chronic kidney disease.
• Monitor electrolyte balance: check serum sodium, potassium and chloride levels during prolonged use.
• Adjust dose in dehydration: reduce or discontinue if the patient shows signs of fluid loss.
• Use caution in bowel obstruction: avoid administration in complete mechanical obstruction without medical supervision.
• Avoid concurrent strong laxatives: do not combine with other osmotic or stimulant laxatives unless directed.
• Store at ambient temperature: keep the solution below 25 °C in the original container, protected from moisture and light.

Movicol Liquide Goût Orange can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Loop diuretics: may exacerbate electrolyte disturbances when combined.
• Sodium‑containing IV fluids: can lead to hypernatremia if given concurrently.
• Potassium‑sparing agents: increase risk of hyperkalaemia due to added potassium load.

Moderate Interactions (Monitor Closely)

• Other laxatives: additive effect on bowel motility may cause diarrhoea.
• Antacids containing magnesium or aluminium: may alter the osmotic balance.
• ACE inhibitors or ARBs: monitor blood pressure and renal function due to potential fluid shifts.